Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

497 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Influence of an oligodendroglial component on the survival of patients with anaplastic astrocytomas: a report of Radiation Therapy Oncology Group 83-02.
Donahue B, Scott CB, Nelson JS, Rotman M, Murray KJ, Nelson DF, Banker FL, Earle JD, Fischbach JA, Asbell SO, Gaspar LE, Markoe AM, Curran W. Donahue B, et al. Among authors: nelson js, nelson df. Int J Radiat Oncol Biol Phys. 1997 Jul 15;38(5):911-4. doi: 10.1016/s0360-3016(97)00126-0. Int J Radiat Oncol Biol Phys. 1997. PMID: 9276354 Free article. Clinical Trial.
Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma.
Prados MD, Scott CB, Rotman M, Rubin P, Murray K, Sause W, Asbell S, Comis R, Curran W, Nelson J, Davis RL, Levin VA, Lamborn K, Phillips TL. Prados MD, et al. Int J Radiat Oncol Biol Phys. 1998 Feb 1;40(3):653-9. doi: 10.1016/s0360-3016(97)00770-0. Int J Radiat Oncol Biol Phys. 1998. PMID: 9486616
Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma--possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: report of the Radiation Therapy Oncology Group Protocol 8302.
Nelson DF, Curran WJ Jr, Scott C, Nelson JS, Weinstein AS, Ahmad K, Constine LS, Murray K, Powlis WD, Mohiuddin M, et al. Nelson DF, et al. Among authors: nelson js. Int J Radiat Oncol Biol Phys. 1993 Jan 15;25(2):193-207. doi: 10.1016/0360-3016(93)90340-2. Int J Radiat Oncol Biol Phys. 1993. PMID: 8380567 Clinical Trial.
Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials.
Simpson JR, Horton J, Scott C, Curran WJ, Rubin P, Fischbach J, Isaacson S, Rotman M, Asbell SO, Nelson JS, et al. Simpson JR, et al. Among authors: nelson js. Int J Radiat Oncol Biol Phys. 1993 May 20;26(2):239-44. doi: 10.1016/0360-3016(93)90203-8. Int J Radiat Oncol Biol Phys. 1993. PMID: 8387988 Clinical Trial.
Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315.
Nelson DF, Martz KL, Bonner H, Nelson JS, Newall J, Kerman HD, Thomson JW, Murray KJ. Nelson DF, et al. Among authors: nelson js. Int J Radiat Oncol Biol Phys. 1992;23(1):9-17. doi: 10.1016/0360-3016(92)90538-s. Int J Radiat Oncol Biol Phys. 1992. PMID: 1572835 Clinical Trial.
Survival comparison of radiosurgery-eligible and -ineligible malignant glioma patients treated with hyperfractionated radiation therapy and carmustine: a report of Radiation Therapy Oncology Group 83-02.
Curran WJ Jr, Scott CB, Weinstein AS, Martin LA, Nelson JS, Phillips TL, Murray K, Fischbach AJ, Yakar D, Schwade JG, et al. Curran WJ Jr, et al. Among authors: nelson js. J Clin Oncol. 1993 May;11(5):857-62. doi: 10.1200/JCO.1993.11.5.857. J Clin Oncol. 1993. PMID: 8487050 Clinical Trial.
Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. Radiation Therapy Oncology Group Study 83-02.
Werner-Wasik M, Scott CB, Nelson DF, Gaspar LE, Murray KJ, Fischbach JA, Nelson JS, Weinstein AS, Curran WJ Jr. Werner-Wasik M, et al. Among authors: nelson js, nelson df. Cancer. 1996 Apr 15;77(8):1535-43. doi: 10.1002/(SICI)1097-0142(19960415)77:8<1535::AID-CNCR17>3.0.CO;2-0. Cancer. 1996. PMID: 8608540 Clinical Trial.
497 results